Herman Sintim, Drug Discovery Professor of Chemistry in the Department of Chemistry at Purdue University, has worked to develop a potential drug compound for treating an aggressive form of leukemia known as acute myeloid leukemia (AML). Chemists have the ability to study proteins that “go rogue,” or initiate cancer within a cell, and develop molecules (drugs) that are able to bind to such proteins and stop the cancer process. Sintim advises students to always follow their passions.